| CARDIOL THERAPEUTICS CL.A |
| Kanada |
| Gesundheit |
| CA14161Y2006 / A2PA9E |
| CT9 (Frankfurt) |
| FRA:CT9, ETR:CT9, CT9:GR |
| - |
| https://www.cardiolrx.com.. |
|
Cardiol Therapeutics Inc. is a clinical-stage biotechnology company that focuses on developing innovative therapies for heart diseases. The company's primary objective is to research and produce anti-..
>Volltext.. |
| 98.95 Mio. EUR |
| 91.92 Mio. EUR |
| - |
| -21.81 Mio. EUR |
| -20.99 Mio. EUR |
| -0.25 EUR |
| 0.08 Mio. EUR |
| 7.01 Mio. EUR |
| -14.62 Mio. EUR |
| 3.53 |
| - |
| 11.27% |
| - |
| - |
| - |
| - |
| CARDIOL |
| 14.02.26 |
|